₹801.65
▲ 2.25%
Delayed · as of 18 Aug 2026
Came to market
- Listed
- 28 Dec 2021
- 4 years 7 months ago
- Issue price
- ₹274.00
- at the offer
- First dividend
- 8 months
- after listing
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY23 | ₹0.60 |
| FY24 | ₹0.60 |
| FY25 | ₹0.80 |
| FY26 | ₹1.00 |
Recent payouts
4 on record since FY23| Type | Amount | Ex-date | Record date | FY |
|---|---|---|---|---|
| FINAL | ₹1.00 | 04 Sep 2025 | ||
| FINAL | ₹0.80 | 20 Sep 2024 | ||
| FINAL | ₹0.60 | 15 Sep 2023 | ||
| FINAL | ₹0.60 | 01 Sep 2022 |
Against the marketIndex yields as of 17 Aug 2026+ Show– Hide
Index dividend yields are published by NSE alongside the closing levels. The dividend index is the fairer comparison: measured against the broad market almost every instrument here looks generous. A higher yield is not automatically better — it can mean a falling price as easily as a rising payout, which is what the chart above separates.
Yield through time
253 sessions · 07 Aug 2025 – 18 Aug 2026Trailing twelve-month payout divided by that session’s closing price, so a move here is either the payout changing or the price changing — the two readings a single current yield cannot tell apart. Ranged 0.10% to 0.28% over this window, ending at 0.12%. Closes and payouts are both split-adjusted, so a split does not appear as a change in yield. Tap or drag the chart to read a single session.
Others in Pharmaceuticals6 instruments+ Show– Hide
Ranked by published trailing-12-month yield. Classification is factual, not a recommendation.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.